Future Research Goals So far, most evidence comes from retrospective studies or case reports, not from large randomized clinical trials, says Tariq, who says that experts are still looking to understand: Whether GLP-1s directly reduce intestinal inflammation How GLP-1s interact with the immune system and the gut microbiome Whether they are as effective in people with active Crohns disease as with those in remission Current research findings show promise, but Tariq encourages her patients to view them as early signals instead of established treatments
The study was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments
A Phase II Trial of Tamoxifen and Bortezomib in Patients with Recurrent Malignant Gliomas
Understanding GLP-1 Medications and Mental Health Concerns GLP-1 medications are now used to treat obesity and type 2 diabetes
Track Your Symptoms: Note if your appetite returns or if you experience any new side effects like nausea or skin irritation
When left untreated, fatty liver disease can lead to inflammation, scarring, and even cirrhosis